The ASSOCIATE study investigators have reported that the I f current inhibitor, ivabradine, is safe, improves exercise performance, and delays the development of ischemia in patients with chronic ...

A recent state-of-the-art review overlooks a “safe and effective” therapy for patients with stable angina and no good treatment options, according to several cardiologists. The coronary sinus reducer ...

This large-scale open clinical trial of a new modified-release formulation of trimetazidine was conducted by 241 cardiologists in 906 patients with stable angina. All patients were required to have ...

Please provide your email address to receive an email when new articles are posted on . The study included data on 32,691 patients with stable CAD from the prospective, observational CLARIFY registry.

Thanks to results from the ORBITA-2 randomized trial, there are now two “evidence-based pathways” for the treatment of patients with stable angina, according to a newly published editorial. Harvey ...

UK: A new analysis of the ORBITA-2 trial has found that patients with stable angina and focal coronary artery disease derive ...

Coronary artery stents are lifesaving for heart attack patients, but new research suggests that the placebo effect may be larger than previously thought. The findings come from the ORBITA trial; a ...

– The IMPROVE-ISCHEMIA Phase 2 clinical trial met the primary endpoint of tolerability and safety; 8-weeks treatment with ninerafaxstat also demonstrated a statistically significant improvement in ...

More than a few people confuse the symptoms of angina with those of a heart attack. (Here are 7 signs you are having a heart attack.) Angina isn’t quite that serious, but it’s close. Think of it as a ...

Despite the availability of a number of antianginal agents, many patients with stable coronary artery disease (CAD) have persistent angina. Even following CABG surgery or percutaneous coronary ...

This large open-label study was conducted by cardiologists, in ten regions of Russia, in patients with stable angina diagnosed at least 6 months previously and with an average of more than three ...